| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INTRALINKS HLDGS INC | 6,490,503 | 77,237,000 | 34.26% | ||
| 2 | FCB Financial Holdings Inc | 4,107,522 | 60,586,000 | 26.88% | ||
| 3 | Anacor Pharmaceuticals Inc | 1,067,892 | 34,440,000 | 15.28% | ||
| 4 | CARA THERAPEUTICS INC | 2,668,057 | 26,601,000 | 11.80% | ||
| 5 | Nephrogenex Inc | 1,326,826 | 17,713,000 | 7.86% | ||
| 6 | REACHLOCAL INC | 2,570,395 | 8,842,000 | 3.92% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001420506-15-000003, filed 2015.01.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
